SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024494
Filing Date
2021-05-06
Accepted
2021-05-06 07:00:36
Documents
58
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krtx-10q_20210331.htm   iXBRL 10-Q 1612691
2 EX-3.1 krtx-ex31_102.htm EX-3.1 149935
3 EX-31.1 krtx-ex311_7.htm EX-31.1 9820
4 EX-31.2 krtx-ex312_8.htm EX-31.2 9801
5 EX-32.1 krtx-ex321_6.htm EX-32.1 8500
  Complete submission text file 0001564590-21-024494.txt   6369634

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA krtx-20210331.xsd EX-101.SCH 47187
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krtx-20210331_cal.xml EX-101.CAL 53321
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krtx-20210331_def.xml EX-101.DEF 130888
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20210331_lab.xml EX-101.LAB 364718
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20210331_pre.xml EX-101.PRE 267493
11 EXTRACTED XBRL INSTANCE DOCUMENT krtx-10q_20210331_htm.xml XML 1115250
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38958 | Film No.: 21895699
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences